Zoetis
Zoetis Inc., headquartered in the United States, is a leading global animal health company dedicated to supporting the health and well-being of livestock and companion animals. Founded in 1952, Zoetis has established itself as a pioneer in the veterinary pharmaceutical industry, with a diverse portfolio that includes vaccines, diagnostics, and therapeutics. With a strong presence in North America, Europe, and Asia, Zoetis is renowned for its innovative products that enhance animal health and productivity. The company’s commitment to research and development has led to significant milestones, including the introduction of groundbreaking treatments that address various health challenges in animals. Recognised for its market leadership, Zoetis continues to set industry standards, making it a trusted partner for veterinarians and animal producers worldwide.
DitchCarbon Score
How does Zoetis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zoetis's score of 60 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zoetis's reported carbon emissions
In 2023, Zoetis reported total carbon emissions of approximately 232,804,000 kg CO2e, comprising 111,637,000 kg CO2e from Scope 1 emissions and 121,167,000 kg CO2e from Scope 2 emissions. Additionally, Scope 3 emissions included about 21,399,000 kg CO2e from business travel and 14,935,000 kg CO2e from employee commuting. This data reflects a commitment to transparency in their sustainability efforts. Zoetis has set ambitious climate commitments, aiming to achieve carbon neutrality in its operations by 2030, specifically targeting a reduction of 18.9% in Scope 1 and 2 emissions. This goal encompasses emissions from manufacturing, research and development, office locations, and fleet vehicles. Furthermore, the company aims to reduce energy intensity in its manufacturing and R&D processes by 5% by 2025, using 2019 as a baseline. The emissions data is sourced directly from Zoetis Inc., with no cascading from a parent or related organization. The company is actively working towards its climate targets, demonstrating a proactive approach to mitigating its carbon footprint in the veterinary pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 193,434,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zoetis is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
